| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/26/2001 | CN1328473A Medicinal aerosol formulation |
| 12/26/2001 | CN1328467A Buffered composition for dialysis |
| 12/26/2001 | CN1328460A Pharmaceutical combination preparations |
| 12/26/2001 | CN1328459A Oral dosage formulations comprising (2S, 3S, 5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol and effective stabilizing amount of alginic acid |
| 12/26/2001 | CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 12/26/2001 | CN1328453A Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 12/26/2001 | CN1328450A Particles coated with granulated crystalline ibuprofen |
| 12/26/2001 | CN1328449A Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or as film-forming auxiliary agent in pharmaceutical for |
| 12/26/2001 | CN1328448A Fentanyl composition for treatment of acute pain |
| 12/26/2001 | CN1328447A Process for producing particles with converted amorphous and/or meta-stable crystalline region into crystalline state |
| 12/26/2001 | CN1328446A Improved fast disintegrating tablet |
| 12/26/2001 | CN1328445A Pressurised metered dose inhalers |
| 12/26/2001 | CN1327854A Composite lysostaphin enzyme spray for oral cavity and its preparing process |
| 12/26/2001 | CN1327851A Caspule for dispelling wind and detoxicating body |
| 12/26/2001 | CN1327838A Niantongbao capsule and its preparing process |
| 12/26/2001 | CN1327836A Instant particles as Chinese medicine for treating AIDS and its preparing process |
| 12/26/2001 | CN1327834A Oral liquid for removing endogenous heat |
| 12/26/2001 | CN1327829A Tea leaf-seed ointment for treating scald and its preparing process |
| 12/26/2001 | CN1327828A Adhesive bandage able to relieve inflammation, astringe and grow muscle and its preparing process |
| 12/26/2001 | CN1327822A Universal red Zn-base ointment for treating injury and its prparing process |
| 12/26/2001 | CN1327806A Compound Cijin capsule |
| 12/26/2001 | CN1327794A Vaginal minocycline suppository |
| 12/26/2001 | CN1327790A Application of pen in drawing line of operation incision and its special pen |
| 12/26/2001 | CN1076624C Nasally administrable compositions |
| 12/26/2001 | CN1076621C Capsule for treatment of rheumatic angitis and its preparation method |
| 12/26/2001 | CN1076619C Moxiburning medicine for acupoint therapy |
| 12/26/2001 | CN1076618C Liquid medicine for treating wound and pain and preparing process thereof |
| 12/26/2001 | CN1076616C Pure natural health-care article for eliminating smoke harm |
| 12/26/2001 | CN1076615C Chinese medicine powder for setting bone |
| 12/26/2001 | CN1076614C Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process |
| 12/26/2001 | CN1076612C Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |
| 12/26/2001 | CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 12/26/2001 | CN1076604C Slow releasing agent of tuduvanine and its preparing method |
| 12/25/2001 | US6333361 Pharmaceutical composition containing zafirlukast |
| 12/25/2001 | US6333332 Storage stability |
| 12/25/2001 | US6333314 Radiosensitizing tumor tissue by administration of formulation comprising cationic liposome, phosphatidylcholine and cholesterol, and encapsulated antisense oligonucleotide |
| 12/25/2001 | US6333054 Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 12/25/2001 | US6333051 Nanogel networks and biological agent compositions thereof |
| 12/25/2001 | US6333050 Oral delivery of discrete units |
| 12/25/2001 | US6333048 Solid medicament form with active agent distributed in flat polymer fragments |
| 12/25/2001 | US6333047 No caking, no deformation, useful in drugs, cosmetics, foods |
| 12/25/2001 | US6333045 Gatifloxacin or its salt and disodium EDTA to prevent coloration; eye, ear or nose drops |
| 12/25/2001 | US6333044 For therapy of inflammation and pain of a traumatic or pathologic origin |
| 12/25/2001 | US6333041 Nontoxic vernix compositions and method of producing |
| 12/25/2001 | US6333023 For therapy of respiratory disorders |
| 12/25/2001 | US6333021 For delivery of therapeutically and/or diagnostically active substance, when in suspension in physiologically acceptable carrier useful as delivery vehicles for therapeutically active agents and/or as contrast agents for echographic imaging |
| 12/25/2001 | CA2233753C Drug delivery system for two or more active substances |
| 12/25/2001 | CA2217950C Metered dose inhaler for albuterol |
| 12/25/2001 | CA2208230C Controlled release formulation (albuterol) |
| 12/25/2001 | CA2184582C Pharmaceutically acceptable dnase formulation |
| 12/25/2001 | CA2172779C Cgrp antagonist used for the treatment of pruritus and ocular or palpebral dysesthesia |
| 12/25/2001 | CA2166517C Cosmetic or dermatologic composition containing at least a ceramide 6 |
| 12/25/2001 | CA2089371C Lateral edge coated controlled release pharmaceutical compositions |
| 12/25/2001 | CA2050188C Antiperspirant containing a hydrophobic macroporous polymer as the suspending agent |
| 12/20/2001 | WO2001096586A1 Antisense modulation of c/ebp alpha expression |
| 12/20/2001 | WO2001096461A1 Polysaccharide based gel |
| 12/20/2001 | WO2001096450A2 Fast cure film forming formulation |
| 12/20/2001 | WO2001096422A1 Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby |
| 12/20/2001 | WO2001096286A2 Urokinase inhibitors |
| 12/20/2001 | WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 12/20/2001 | WO2001095951A1 Method of using lectins for contraception and prophylaxis agains t diseases transmittable by sexual contact and condom containing lectins |
| 12/20/2001 | WO2001095941A1 Solid dispersions and medicines |
| 12/20/2001 | WO2001095939A1 Novel solid dispersion compositions |
| 12/20/2001 | WO2001095933A2 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | WO2001095930A1 Method of photoreduction of hemoglobin vesicles |
| 12/20/2001 | WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation |
| 12/20/2001 | WO2001095918A1 A process for producing and packaging lactic acid bacteria tablets |
| 12/20/2001 | WO2001095914A1 Lipids for modulating immune response |
| 12/20/2001 | WO2001095912A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED |
| 12/20/2001 | WO2001095900A1 Pharmaceutical disinfectants comprising usnic and essential oils |
| 12/20/2001 | WO2001095899A2 Pharmaceutical compositions comprising cannabidiol derivatives |
| 12/20/2001 | WO2001095890A2 Oral pharmaceutical compositions containing terbinafine |
| 12/20/2001 | WO2001095889A1 Plaster |
| 12/20/2001 | WO2001095888A1 Bioadhesive progressive hydration tablets |
| 12/20/2001 | WO2001095887A1 Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form |
| 12/20/2001 | WO2001095886A1 Bioavailable dosage form of isotretinoin |
| 12/20/2001 | WO2001095885A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrin antagonist |
| 12/20/2001 | WO2001095884A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 12/20/2001 | WO2001095883A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095882A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
| 12/20/2001 | WO2001095881A1 Pharmaceutical anti-inflammatory aerosol formulation |
| 12/20/2001 | WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095879A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
| 12/20/2001 | WO2001095878A1 Process for the preparation of a sterile ointment containing acyclovir |
| 12/20/2001 | WO2001095877A2 Porous celecoxib matrices and methods of manufacture thereof |
| 12/20/2001 | WO2001095875A1 Low molecular weight polymeric compositions |
| 12/20/2001 | WO2001095874A2 Highly efficient delivery of a large therapeutic mass aerosol |
| 12/20/2001 | WO2001095844A1 Support film for self-adhesive laminates with reduced contact area |
| 12/20/2001 | WO2001078725A3 Modified release formulations containing a hypnotic agent |
| 12/20/2001 | WO2001074396A8 Composition and method for promoting oral health |
| 12/20/2001 | WO2001070154A9 Device and method for treating urinary incontinence in females |
| 12/20/2001 | WO2001064164A3 Nanocapsule encapsulation system and method |
| 12/20/2001 | WO2001062267A3 Oral gel containing sulfurated amino acid compounds |
| 12/20/2001 | WO2001054663A3 Surfactant free topical compositions and method for rapid preparation thereof |
| 12/20/2001 | WO2001052888A3 Improved dna vaccines for production-type animals |
| 12/20/2001 | WO2001052816A3 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 12/20/2001 | WO2001050872A3 Method for produce sanitation using bacteriophages |
| 12/20/2001 | WO2001043545A3 Fluid insecticidal formulations for dermal treatment of parasitic insect larvae |
| 12/20/2001 | WO2001039745A3 Aerosol composition comprising formoterol |